Clinical Trials Logo

Valve Regurgitation, Tricuspid clinical trials

View clinical trials related to Valve Regurgitation, Tricuspid.

Filter by:
  • None
  • Page 1

NCT ID: NCT05628779 Enrolling by invitation - Clinical trials for Cardiac Catheterization

Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation

TRACE-NL
Start date: December 12, 2022
Phase: N/A
Study type: Interventional

This is a national multicenter, open-label, randomized controlled trial to show superiority of edge-to-edge Transcatheter Tricuspid Valve repair (TTVr) on top of the Standard Of Care (SOC; heart failure medication) over the SOC alone in patients with symptomatic severe Tricuspid Regurgitation (TR) in the Netherlands.

NCT ID: NCT03270514 Completed - Clinical trials for Coronary Artery Disease

Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride

Start date: November 15, 2018
Phase: Phase 3
Study type: Interventional

The aim of this study is to evaluate the analgesic efficacy and safety of wound infiltration with liposomal bupivacaine (LB) in patients undergoing cardiac surgery with sternotomy and cardiopulmonary bypass (CPB) and compare it with bupivacaine hydrochloride infiltration